Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC).
about
Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potentialImpact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes.Simvastatin Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of Multiple Myeloma.Protective effect of GDNF-engineered amniotic fluid-derived stem cells on the renal ischaemia reperfusion injury in vitro.Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway.
P2860
Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Simvastatin induces osteogenic ...... esenchymal stem cells (AFMSC).
@en
Simvastatin induces osteogenic ...... c fluid mesenchymal stem cells
@nl
type
label
Simvastatin induces osteogenic ...... esenchymal stem cells (AFMSC).
@en
Simvastatin induces osteogenic ...... c fluid mesenchymal stem cells
@nl
prefLabel
Simvastatin induces osteogenic ...... esenchymal stem cells (AFMSC).
@en
Simvastatin induces osteogenic ...... c fluid mesenchymal stem cells
@nl
P2093
P2860
P356
P1476
Simvastatin induces osteogenic ...... esenchymal stem cells (AFMSC).
@en
P2093
Adrianade Aguiar Debes
Felipe de Lara Janz
Giovani Marino Favero
Milton Sérgio Bohatch
Sergio Paulo Bydlowski
P2860
P304
P356
10.1111/FCP.12006
P577
2012-10-24T00:00:00Z